ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging"

  • Abstract Number: 279 • 2019 ACR/ARP Annual Meeting

    Comparison of Carotid Ultrasound and Coronary Artery Calcium Score in Cardiovascular Risk Stratification of Patients with Inflammatory Rheumatic Diseases

    Keith Colaco1, Elsie Nguyen 2, Shadi Akhtari 3, Paula Harvey 3 and Lihi Eder 4, 1University of Toronto, Women's College Hospital, University Health Network, Toronto, ON, Canada, 2University Health Network, Toronto, ON, Canada, 3Women's College Hospital, Toronto, ON, Canada, 4Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada

    Background/Purpose: The value of non-invasive vascular imaging for cardiovascular (CV) risk stratification of patients with inflammatory rheumatic diseases is unclear. Measures of atherosclerosis including coronary…
  • Abstract Number: 285 • 2019 ACR/ARP Annual Meeting

    Thermal Imaging in Rheumatoid Arthritis: A Comparative Analysis with Ultrasonography and Clinical Joint Assessment

    York Kiat Tan1, Cassandra Hong 1, HuiHua Li 2, John Carson Allen Jr 3 and Julian Thumboo 1, 1Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore, 2Health Services Research, Singapore General Hospital, Singapore, Singapore, 3Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore

    Background/Purpose: The potential of thermal imaging in detecting joint inflammation in rheumatoid arthritis (RA) has not been well studied or compared with other approaches in…
  • Abstract Number: 297 • 2019 ACR/ARP Annual Meeting

    Ultrasound and Magnetic Resonance Imaging Evaluation of the Fingers’ Joints of Psoriatic Arthritis Patients – Interim Analysis

    Ari Polachek1, Victoria Furer 2, Mirna Zureik 2, Sharon Nevo 2, Liran Mendel 2, David Levartovsky 3, Jonathan Wollman 4, Valerie Aloush 5, Mark Berman 6, Ilana Kaufman 6, Yael Lahat 2, Hagit Sarbagil-Maman 7, Sara Borok 6, Adi Broyde 6, Lihi Eder 8, Daphna Paran 1, Iris Eshed 9 and Ori Elkayam 10, 1Tel-Aviv Sourasky medical center, Tel Aviv, Israel, 2Sourasky Medical Center, Tel-Aviv, Israel, 3Sourasky medical center, Tel Aviv, Israel, 4Sourasky Medical Center, Herzelia, Israel, 5Tel Aviv Sourasky medical center, Tel Aviv, 6Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 7Tel-Aviv Sourasky medical center, Qiryat-Ono, Israel, 8Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada, 9Sheba Medical Center, Tel-Aviv, Israel, 10Rheumatology Department, Tel Aviv Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Israel., Tel Aviv, Israel

    Background/Purpose: Psoriatic arthritis (PsA) is an inflammatory disease affecting up to 30% of psoriasis patients. PsA can involve both the peripheral and axial skeleton and…
  • Abstract Number: 568 • 2019 ACR/ARP Annual Meeting

    Understanding mNY Radiograph Score Discordance in Axial Spondyloarthritis Clinical Trials Using Imaging Criteria for Subject Eligibility

    Farhan Syed1, Kassel Fotinos-Hoyer 2, Michael O'Connor 3, Maureen Li 3, Bryan Hermannsson 2, Nicholas Enus 3, Sayali Karve 3, Manish Sharma 4, Gabriele Pradella 3, Robert B.M. Landewé 5, Xenofon Baraliakos 6 and Sarah Warner 3, 1Parexel, Billerica, MA, 2Parexel, Berlin, Germany, 3Parexel, Billerica, 4Parexel, Hyderabad, India, 5Amsterdam University Medical Center, Amsterdam, Netherlands, 6Rheumatology Department, Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) is typically radiographically confirmed on the sacroiliac joint (SIJ) as assessed by the modified New York (mNY) criteria. In clinical trials,…
  • Abstract Number: 854 • 2019 ACR/ARP Annual Meeting

    Do Smoking and Socio-economic Factors Independently Influence Imaging Outcomes in Axial Spondyloarthritis? Five-year Data from the DESIR Cohort

    Elena Nikiphorou1, Sofia Ramiro 2, Alexandre Sepriano 3, Adeline Ruyssen Witrand 4, Robert B.M. Landewé 5 and Désirée van der Heijde 3, 1King's College London, London, United Kingdom, 2Leiden University Medical Center and Zuyderland Medical Centre, Leiden, Netherlands, 3Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology center, Pierre Paul Riquet Hospital, CHU of Toulouse, Paul Sabatier University, UMR 1027, Inserm, France, Toulouse, France, 5Amsterdam University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Smoking and systemic inflammation have been shown to independently associate with radiographic spinal progression in patients with axSpA. Evidence suggests that certain socioeconomic (SE)…
  • Abstract Number: 959 • 2019 ACR/ARP Annual Meeting

    A Novel Image Analysis Program, “CytoSkaler”, Demonstrates That Anti-Vimentin Antibody Affinity Maturation in Lupus Tubulointerstitial Nephritis Also Results in More Selective Antigen Targeting

    Andrew Kinloch1, Aazam Mohsin 1, Yuta Asano 1, Carole Henry 1, Nirit Mor Vaknin 2, Maureen Legendre 2, Patrick Wilson 1, David Markovitz 2 and Marcus Clark 1, 1University of Chicago, Chicago, IL, 2University of Michigan, Ann Arbor, MI

    Background/Purpose: Vimentin is a dominant target of B-cells selected in lupus tubulointerstial inflammation (TII), a predictor of renal failure. The origins of anti-vimentin antibodies (AVA)…
  • Abstract Number: 1172 • 2019 ACR/ARP Annual Meeting

    The Relationship Between Subclinical Inflammation and Bone Damage in Patients with Rheumatoid Arthritis Using Multimodality Imaging

    Scott Brunet 1, Peter Salat 2, Glen Hazlewood 3, Klaus Engelke 4, Cheryl Barnabe 3 and Sarah Manske3, 1University of Calgary, Calgary, Canada, 2University of Calgary, Calary, Canada, 3University of Calgary, Calgary, AB, Canada, 4Erlangen University Hospital, Department of Medicine, Erlangen, Germany

    Background/Purpose: Many RA patients in clinical remission have evidence of bone marrow edema (BME) on magnetic resonance imaging (MRI), with radiographic bone damage progression appearing…
  • Abstract Number: 1177 • 2019 ACR/ARP Annual Meeting

    Near Infrared Indocyanine Green Imaging Reveals Altered Anatomy and Diminished Function in Lymphatic Vessels in the Hands of Rheumatoid Arthritis Patients During Flare

    Richard Bell1, Homaira Rahimi 2, Alicia Lieberman 2, Ronald Wood 2, Edward Schwarz 3 and Christopher Ritchlin 4, 1University of Rochester Medical Center, Rochester, NY, 2University of Rochester Medical Center, Rochester, 3University of Rochester, Rochester, NY, 4Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY

    Background/Purpose: Near infrared (NIR) imaging of indocyanine green (ICG) in rheumatoid arthritis (RA) models identified abnormal lymphatic vessel (LV) function, which can be quantified as…
  • Abstract Number: 1877 • 2019 ACR/ARP Annual Meeting

    Romosozumab Improves Lumbar Spine Bone Mineral Density and Bone Strength Greater Than Alendronate as Assessed by Quantitative Computed Tomography and Finite Element Analysis in the ARCH Trial

    Jacques Brown1, Arkadi Chines 2, Roland Chapurlat 3, Joseph Foldes 4, Xavier Nogues 5, Roberto Civitelli 6, Tobias De Villiers 7, Fabio Massari 8, Cristiano A. Zerbini 9, Wenjing Yang 2, Chris Recknor 10 and Cesar Libanati 11, 1CHU de Quebec Research Centre and Laval University, Quebec, QC, Canada, 2Amgen Inc., Thousand Oaks, CA, 3INSERM UMR 1033, Université de Lyon, Lyon, France, 4Hadassah Hebrew University Medical Center, Jerusalem, Israel, 5IMIM Institut Hospital del Mar d’Investigacions Mèdiques, Barcelona, Spain, 6Washington University School of Medicine, St. Louis, MO, 7Stellenbosch University, Stellenbosch, South Africa, 8Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina, 9Centro Paulista de Investigação Clinica, São Paulo, Brazil, 10United Osteoporosis Centers, Gainesville, GA, 11UCB Pharma, Brussels, Belgium

    Background/Purpose: Recent evidence suggests BMD achieved during treatment is a reliable surrogate for fracture risk reduction (Bouxsein JBMR 2019). Romosozumab (Romo) is a bone-forming agent…
  • Abstract Number: 1919 • 2019 ACR/ARP Annual Meeting

    Development of a Multi-Modality Imaging Approach to Evaluate Lupus Nephritis

    Amit Saxena 1, David Karp 2, Brad Rovin 3, Mikael Boesen 4, Olga Kubassova 5, Claire Dykas 6, Anthony Yeo 7 and Peter Lipsky8, 1New York University School of Medicine, New York, NY, 2UTSouthwestern Medical Center, Dallas, TX, 3The Ohio State University Medical Center, Columbus, OH, 4Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, 5Image Analysis Group, London, United Kingdom, 6AmpelBioSolutions, Charlottesville, VA, 7RILITE Research Institute, Charlottesville, VA, 8AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: Lupus nephritis (LN) remains a significant cause of morbidity and mortality in subjects with Systemic Lupus Erythematosus (SLE). The gold standard for evaluation of…
  • Abstract Number: 2923 • 2019 ACR/ARP Annual Meeting

    Clinical Subsets in Giant Cell Arteritis

    K Bates Gribbons1, Cristina Ponte 2, Anthea Craven 3, Joanna Robson 4, Ravi Suppiah 5, Richard Watts 6, Raashid Luqmani 3, Peter Merkel 7 and Peter C. Grayson 8, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Department of Rheumatology, Hospital de Santa Maria, Lisbon, Portugal, 3University of Oxford, Oxford, United Kingdom, 4Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, 5Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, 6Norwich Medical School, University of East Anglia, Norwich, United Kingdom, 7University of Pennsylvania, Philadelphia, PA, 8National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health, Bethesda, MD, Bethesda, MD

    Background/Purpose: Giant cell arteritis (GCA) is a clinically heterogeneous disease.  Disease subsets based upon cranial versus extracranial artery involvement have been proposed.  The study objective…
  • Abstract Number: 666 • 2018 ACR/ARHP Annual Meeting

    Inflammation on MRI of the Sacroiliac Joints Is Highly Associated with Structural Damage in Axial Spondyloarthritis Patients in Clinical Practice: Data from the ASAS and DESIR Cohorts

    Alexandre Sepriano1, Sofia Ramiro1,2, Robert B.M. Landewé3,4, Maxime Dougados5, Désirée van der Heijde6 and Martin Rudwaleit7, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Zuyderland Medical Center, Heerlen & Leiden University Medical Center, Leiden, Netherlands, 3Zuyderland Medical Center, Heerlen, Netherlands, 4Amsterdam Rheumatology & Immunology Center, Amsterdam, the Netherlands, Amsterdam, Netherlands, 5Department of Rheumatology, Paris Descartes University and Cochin Hospital, Paris, France, 6Leiden University Medical Centre, Leiden, Netherlands, 7Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany

    Background/Purpose: The effect of MRI-detected inflammation on the development of radiographic damage at the sacroiliac joints (SIJ) level in patients (pts) with axial SpA (axSpA)…
  • Abstract Number: 2212 • 2018 ACR/ARHP Annual Meeting

    Feasibility and Performance of HR-pQCT-Derived Joint Space Width Measurement As Outcome Parameter in Arthropathic Disease – Lessons from Hemochromatosis Arthropathy

    Ursula Heilmeier1, Andrew J Burghardt1, Puneet Kapoor2, Georg Schett3, Reinhard Voll4 and Stephanie Finzel5, 1Department of Radiology & Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Department of Internal Medicine 3 – Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany, 4Clinic for Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany, 5Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

    Background/Purpose: High resolution peripheral quantitative computed tomography (HR-pQCT) allows in vivo 3 D imaging of human joint microstructure and joint space width (JSW) at an…
  • Abstract Number: 677 • 2018 ACR/ARHP Annual Meeting

    Structural Damage Characteristics of Patients with Ankylosing Spondylitis in China

    Weiping Kong1, Caroline Jefferies2, Thomas Learch3, Jinrui Cui4, Xiaowei Gan1, Nan Zhang1, Yingze Zhang1, Jianming Wang1, Qingwen Tao1, Xiaoping Yan1, Michael Weisman5 and Mariko Ishimori6, 1China-Japan Friendship Hospital, Beijing, China, 2Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 3Radiology, Cedars-Sinai Medical Center, Los Angeles, CA, 4Cedars-Sinai Medical Center, Los Angeles, CA, 5Harbor UCLA Medical Center, Los Angeles, CA, 6Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Structural damage is a major cause of poor outcomes in patients with ankylosing spondylitis (AS). In China, structural damage characteristics of AS are rarely…
  • Abstract Number: 2222 • 2018 ACR/ARHP Annual Meeting

    Construct Validity of Provisional Remission Criteria for Gout: A Dual Energy CT Study

    Nicola Dalbeth1, Christopher Frampton2, Maple Fung3, Scott Baumgartner3, Savvas Nicolaou4 and Hyon K. Choi5, 1University of Auckland, Auckland, New Zealand, 2University of Otago, Christchurch, New Zealand, 3Formerly Ardea Biosciences, San Diego, CA, 4Radiology, University of British Columbia, Vancouver, BC, Canada, 5Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Provisional domains and definitions for gout remission criteria have been proposed using consensus methodology (de Lautour et al, Arthritis Care Res 2016). These criteria…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 36
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology